See more : Polo Queen Industrial and Fintech Limited (PQIF.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Henan Jinyuan Hydrogenated Chemicals Co., Ltd. (2502.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Henan Jinyuan Hydrogenated Chemicals Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Federal Home Loan Mortgage Corporation (FMCCT) Income Statement Analysis – Financial Results
- Energy Resources of Australia Ltd (ERA.AX) Income Statement Analysis – Financial Results
- Boltek Holdings Limited (8601.HK) Income Statement Analysis – Financial Results
- AOKI Holdings Inc. (8214.T) Income Statement Analysis – Financial Results
- Chang Jiang Shipping Group Phoenix Co.,Ltd (000520.SZ) Income Statement Analysis – Financial Results
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. (2502.HK)
About Henan Jinyuan Hydrogenated Chemicals Co., Ltd.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. engages in the processing, production, distribution, and sale of hydrogenated benzene-based chemicals and energy products in the People's Republic of China. Its hydrogenated benzene-based chemicals include pure benzene, toluene, and xylene; and energy products comprising liquefied natural gas (LNG) and coal gas. The company is also involved in the trading and retail of LNG and oil products; operation of oil and gas stations; steam services; and provision of multimodal transportation, warehousing, and distribution services for coal products. It serves nylon and fertilizers manufacturers, refined oil manufacturers, and other chemical companies, as well as industrial users, and trading and retail customers. The company was incorporated in 2012 and is headquartered in Jiyuan, China. Henan Jinyuan Hydrogenated Chemicals Co., Ltd. operates as a subsidiary of Henan Jinma Energy Company Limited.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 2.33B | 2.30B | 1.46B | 1.02B |
Cost of Revenue | 2.18B | 2.02B | 1.31B | 928.92M |
Gross Profit | 148.80M | 285.51M | 142.80M | 91.41M |
Gross Profit Ratio | 6.39% | 12.40% | 9.81% | 8.96% |
Research & Development | 0.00 | 1.29M | 532.04K | 711.78K |
General & Administrative | 31.32M | 27.71M | 2.21M | 3.08M |
Selling & Marketing | 18.42M | 13.49M | 9.37M | 9.28M |
SG&A | 49.74M | 39.67M | 26.57M | 26.86M |
Other Expenses | 99.06M | 1.67M | -10.61K | 303.73K |
Operating Expenses | 148.80M | 39.67M | 26.57M | 26.86M |
Cost & Expenses | 2.33B | 2.06B | 1.34B | 955.78M |
Interest Income | 5.20M | 3.27M | 3.00M | 3.17M |
Interest Expense | 6.06M | 7.04M | 2.16M | 7.20M |
Depreciation & Amortization | 58.52M | 63.60M | 60.11M | 48.59M |
EBITDA | 163.47M | 266.82M | 176.34M | 113.14M |
EBITDA Ratio | 7.02% | 13.44% | 12.12% | 11.09% |
Operating Income | 109.47M | 245.84M | 116.24M | 64.55M |
Operating Income Ratio | 4.70% | 10.68% | 7.99% | 6.33% |
Total Other Income/Expenses | -10.58M | -6.44M | -6.39M | -8.76M |
Income Before Tax | 98.89M | 238.48M | 109.07M | 58.03M |
Income Before Tax Ratio | 4.24% | 10.36% | 7.50% | 5.69% |
Income Tax Expense | 16.57M | 40.30M | 30.91M | 15.84M |
Net Income | 54.93M | 121.38M | 59.14M | 24.48M |
Net Income Ratio | 2.36% | 5.27% | 4.06% | 2.40% |
EPS | 0.06 | 0.15 | 0.07 | 0.03 |
EPS Diluted | 0.06 | 0.15 | 0.07 | 0.03 |
Weighted Avg Shares Out | 955.64M | 955.64M | 955.64M | 955.64M |
Weighted Avg Shares Out (Dil) | 955.64M | 955.64M | 955.64M | 955.64M |
Source: https://incomestatements.info
Category: Stock Reports